A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis

- Ban, M., McCauley, J. L., Dudbridge, F., Wason, J., Robertson, N. P., De Jager, P. L., Hafler, D. A., Barcellos, L. F., Ivinson, A. J., Sexton, D., Oksenberg, J. R., Hauser, S. L., Zuvich, R., Pericak-Vance, M. A., Haines, J., Compston, A., Sawcer, S., Baker, A., Bergamaschi, L., Cox, M., Kemppinen, A., D'Alfonso, S., Guerini, F. R., Lechner-Scott, J.

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

- Lorscheider, J., Kuhle, J., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo-Tello, C., Lechner-Scott, J., Pucci, E., Solaro, C., Slee, M., Izquierdo, G., Van Pesch, V., Sanchez Menoyo, J. L., van der Walt, A., Butzkueven, H., Kappos, L., Kalincik, T., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A.

Anxiety, depression and fatigue at 5-year review following CNS demyelination

- Simpson, S., Tan, H., Williams, D., van der Mei, I., Ausimmune/AusLong Investigators Group,, Otahal, P., Taylor, B., Ponsonby, A.-L., Lucas, R. M., Blizzard, L., Valery, P. C., Lechner-Scott, J., Shaw, C.

BREMSO: a simple score to predict early the natural course of multiple sclerosis

- Bergamaschi, R., Montomoli, C., Boz, C., Iuliano, G., Zwanikken, C., Petersen, T., Lechner-Scott, J., Hupperts, R., Butzkueven, H., Pucci, E., Oreja-Guevara, C., Cristiano, E., Mallucci, G., Pia Amato, M. P., Havrdova, E., Fernandez-Bolanos, R., Spelman, T., Trojano, M., Lugaresi, A., Izquierdo, G., Grand'Maison, F., Duquette, P., Shaygannejad, V., Alroughani, R., Grammond, P.

Central vein sign for multiple sclerosis: a systematic review and meta-analysis

- Bhandari, A., Xiang, H., Lechner-Scott, J., Agzarian, M.

Familial recurrence risks for multiple sclerosis in Australia

- O'Gorman, C., Freeman, S., Kilpatrick, T. J., Lechner-Scott, J., Moscato, P., Perreau, V. M., Scott, R. J., Stankovich, J., Stewart, G. J., Chapman, C., Marriot, M., Tanner, M., Taylor, B. V., Tubridy, N., Wiley, J., Butzkueven, H., Broadley, S. A., Bahlo, M., Booth, D. R., Brown, M. A., Foote, S. J., Griffiths, L. R.

Fluctuations of MS births and UV-light exposure

- Verheul, F., Smolders, J., Comi, G., Izquierdo, G., Grammond, P., Lus, G., Petersen, T., Bergamaschi, R., Giuliani, G., Boz, C., Coniglio, G., Van Pesch, V., Trojano, M., Lechner-Scott, J., Cavalla, P., Granella, F., Avolio, C., Fiol, M., Poehlau, D., Saladino, M. L., Gallo, P., Deri, N., Oleschko Arruda, W., Lepore, V., Paine, M., Ferro, M., Barnett, M., Cabrera-Gomez, J. A., Slee, M., Moore, F., Shaw, C., Petkovska-Boskova, T., Rutherford, M., Engelsen, O., Zwanikken, C., Damoiseaux, J., Hupperts, R., Amato, M. P., Grand'Maison, F., Butzkueven, H., Marrosu, M., Duquette, P.

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci

- The International Multiple Sclerosis Genetics Consortium, Esposito, F., Patsopoulos, N. A., Lechner-Scott, J., Goris, A., Dobosi, R., Dubois, B., Rioux, J. D., Oturai, A. B., Sondergaard, H. B., Sellebjerg, F., Sorensen, P. S., Reunanen, M., Cepok, S., Koivisto, K., Cournu-Rebeix, I., Fontaine, B., Winkelmann, J., Gieger, C., Infante-Duarte, C., Zipp, F., Bergamaschi, L., Leone, M., Bergamaschi, R., Kockum, I., Cavalla, P., Lorentzen, A. R., Mero, I. L., Celius, E. G., Harbo, H. F., Spurkland, A., Comabella, M., Brynedal, B., Alfredsson, L., Bernardinelli, L., Leppa, V., Robertson, N. P., Hawkins, C. P., Barcellos, L. F., Beecham, G., Bush, W., Cree, B. A. C., Daly, M. J., Ivinson, A. J., Aubin, C., Compston, A., Booth, D. R., D'Alfonso, S., Haines, J. L., Hauser, S. L., Hemmer, B., Hillert, J., McCauley, J. L., Oksenberg, J., Olsson, T., Palotie, A., Peltonen, L., Heard, R. N., Pericak-Vance, M. A., Saarela, J., Sawcer, S. J., Stranger, B., Boneschi, F. M., Comi, G., Hafler, D. A., de Bakker, P. I. W., De Jager, P. L., Stewart, G. J., Cox, M., Scott, R. J.

IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

- Malhotra, S., Morcillo-Suárez, C., Chan, A., Vandenbroeck, K., Navarro, A., Bustamante, M. F., Rio, J., Akkad, D. A., Giacalone, G., Sánchez, A. J., Leyva, L., Alvarez-Lafuente, R., Brassat, D., Zettl, U. K., Oksenberg, J., Montalban, X., Comabella, M., Goertsches, R., Lechner-Scott, J., Urcelay, E., Fernández, O., Drulovic, J., García-Merino, A., Boneschi, F. Martinelli

Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis

- Graves, M. C., Benton, M., Lea, R. A., Boyle, M., Tajouri, L., Macartney-Coxson, D., Scott, R. J., Lechner-Scott, J.

Natural killer cell subpopulations are associated with MRI activity in a relapsing-remitting multiple sclerosis patient cohort from Australia

- Caruana, P., Lemmert, K., Ribbons, K., Lea, R., Lechner-Scott, J.

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

- Mahurkar, S., Moldovan, M., Jokubaitis, V. G., McKay, F. C., Gatt, P. N., Fabis-Pedrini, M. J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A. G., Slee, M., Taylor, B. V., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M.

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

- Spelman, T., Mekhael, L., Grammond, P., Barnett, M., Lechner-Scott, J., Alroughani, R., Trojano, M., Lugaresi, A., Granella, F., Pucci, E., Vucic, S., Burke, T., Butzkueven, H., Hodgkinson, S., Havrdova, E., Horakova, D., Duquette, P., Izquierdo, G., Grand'Maison, F.

The audio recorded cognitive screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics

- Lechner-Scott, J., Kerr, T., Spencer, B., Agland, S., Lydon, A., Schofield, P. W.

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

- Lechner-Scott, J., Spencer, B., Girard, M., Grammond, P., Oreja-Guevara, C., Hupperts, R., Bergamaschi, R., Boz, C., Giuliani, G., Van Pesch, V., Iuliano, G., Fiol, M., De Malmanche, T., Attia, J.R., Fitzgerald, M., Trojano, M., Grand'Maison, F., Antonio C Gomez, J., Izquierdo, G., Duquette, P.

The Multiple Sclerosis Severity Score (MSSS) re-examined: EDSS rank stability in the MSBase dataset increases five years after onset of multiple sclerosis

- Gray, O. M., Jolley, D., Lechner-Scott, J., Zwanikken, C., Trojano, M., Grand'Maison, F., Duquette, P., Grammond, P., Bergamaschi, R., Giuliani, G., Taffi, R.

Uveitis and optic perineuritis in the context of myelin oligodendrocyte glycoprotein antibody seropositivity

- Ramanathan, S., Fraser, C., Curnow, S. R., Ghaly, M., Leventerg, R. J., Lechner-Scott, J., Henderson, A., Reddel, S., Daled, R. C., Brilot, F.